<PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">39368587</PMID><DateRevised><Year>2024</Year><Month>10</Month><Day>20</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1879-0003</ISSN><JournalIssue CitedMedium="Internet"><Volume>281</Volume><Issue>Pt 1</Issue><PubDate><Year>2024</Year><Month>Oct</Month><Day>03</Day></PubDate></JournalIssue><Title>International journal of biological macromolecules</Title><ISOAbbreviation>Int J Biol Macromol</ISOAbbreviation></Journal><ArticleTitle>SARS-CoV-2 S protein harbors furin cleavage site located in a short loop between antiparallel β-strand.</ArticleTitle><Pagination><StartPage>136020</StartPage><MedlinePgn>136020</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.ijbiomac.2024.136020</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0141-8130(24)06829-6</ELocationID><Abstract><AbstractText>Furin cleavage site (FCS) of the SARS-CoV-2 S protein, which connects the S1/S2 junction, is essential for facilitating fusion with the host cells. Wild-type (Wt) SARS-CoV-2 S protein, PDB ID: 6yvb, lacks a sequence of amino acid residues, including the FCS that links the S1/S2 junction. For the first time, we demonstrated that a stretch of 14 amino acid residues (677QTNSPRRARSVASQ689) forms an antiparallel β-sheet comprising of PRRAR sequence in the FCS within a short loop. Upon comparing the loop content of the S1/S2 junction with that of Wt SARS-CoV-2 containing PRRAR in the FCS, we observed a decrease in antiparallel β-sheet content and an increase in loop content in the B.1.1.7 variant with HRRAR in the FCS. This short loop within antiparallel β-sheet can serve as a docking site for various proteases, including TMPRSS2 and α1AT. We performed a 300-ns simulation of the SARS-CoV-2 receptor binding domain (RBD) using several antibacterial and antiviral ligands commonly used to treat various infections. Our findings indicate that the receptor binding domain (RBD) comprising the receptor binding motif (RBM) utilizes β6 and a significant portion of the loop to bind with ligands, suggesting its potential for treating SARS-CoV-2 infections.</AbstractText><CopyrightInformation>Copyright © 2024 The Authors. Published by Elsevier B.V. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Bashir</LastName><ForeName>Arif</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Clinical Biochemistry &amp; Biotechnology, Government College for Women, Nawa-Kadal, Srinagar 190002, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Shun</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Immunology, School of Basic Medical Sciences, Chengdu Medical College, Chengdu, Sichuan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ye</LastName><ForeName>Yu</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>College of Animal Science and Technology, Jiangxi Agricultural University, Nanchang, Jiangxi 330045, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zheng</LastName><ForeName>Qingcong</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>Department of Spinal Surgery, the First Affiliated Hospital of Fujian Medical University, Fuzhou 350004, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Knanghat</LastName><ForeName>Rajani</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Biotechnology, Indian Institute of Technology, Chennai 600036, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bashir</LastName><ForeName>Fahim</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Environmental Science, University of Kashmir, 190006, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shah</LastName><ForeName>Naveed Nazir</ForeName><Initials>NN</Initials><AffiliationInfo><Affiliation>Department of Chest Medicine, Government Medical College, Srinagar, Jammu and Kashmir 190001, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Debin</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, Children's Affiliated Hospital of Zhengzhou University, Zhengzhou 450018, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xue</LastName><ForeName>Mengzhou</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Cerebrovascular Diseases, The Second Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan 450014, China. Electronic address: xuemengzhou@zzu.edu.cn.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Huiqing</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, West China Second University Hospital, Sichuan University, Chengdu 610041, China. Electronic address: wanghuiqing@scu.edu.cn.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zheng</LastName><ForeName>Chunfu</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Microbiology, Immunology and Infectious Diseases, University of Calgary, Calgary, Alberta, Canada. Electronic address: zheng.alan@hotmail.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>03</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Int J Biol Macromol</MedlineTA><NlmUniqueID>7909578</NlmUniqueID><ISSNLinking>0141-8130</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Alpha1 antitrypsin</Keyword><Keyword MajorTopicYN="N">Angiotensin-converting enzyme 2 receptor</Keyword><Keyword MajorTopicYN="N">Antiparallel β-strand</Keyword><Keyword MajorTopicYN="N">Furin cleavage site (FCS)</Keyword><Keyword MajorTopicYN="N">Receptor-binding motif</Keyword><Keyword MajorTopicYN="N">Receptor-binding protein</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">Transmembrane protease serine 2</Keyword></KeywordList><CoiStatement>Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>3</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>8</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>9</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>6</Day><Hour>16</Hour><Minute>20</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>6</Day><Hour>16</Hour><Minute>20</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>5</Day><Hour>19</Hour><Minute>13</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39368587</ArticleId><ArticleId IdType="doi">10.1016/j.ijbiomac.2024.136020</ArticleId><ArticleId IdType="pii">S0141-8130(24)06829-6</ArticleId></ArticleIdList></PubmedData></PubmedArticle>